Texas Codes homeSearch Texas
Tex. CodesHuman Resources CodeTitle 2. Human Services and Protective Services in GeneralSubtitle C. Assistance ProgramsChapter 36. Health Care Program Fraud Prevention

Tex. Hum. Res. Code § 36.104 (2026)

State Decision; Continuation Of Action

Edition and currency
laws through the 89th Legislature (2025). The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTlaws through the 89th Legislature (2025) ACTIVE · 11 IN 5Y cited 2008–2026 19citing cases
At a glance

Courts have cited this section in 19 opinions since 2008, 11 of them in the last five years. The most litigated part is subsection (b) (9 cases).

Sec. 36.104. STATE DECISION; CONTINUATION OF ACTION. (a) Not later than the last day of the period prescribed by Section 36.102(c) or an extension of that period as provided by Section 36.102(d), the state shall:

(1) proceed with the action; or

(2) notify the court that the state declines to take over the action.

(b) If the state declines to take over the action, the person bringing the action may proceed without the state's participation. A person proceeding under this subsection may recover for an unlawful act for a period of up to six years before the date the lawsuit was filed, or for a period beginning when the unlawful act occurred until up to three years from the date the state knows or reasonably should have known facts material to the unlawful act, whichever of these two periods is longer, regardless of whether the unlawful act occurred more than six years before the date the lawsuit was filed. Notwithstanding the preceding sentence, in no event shall a person proceeding under this subsection recover for an unlawful act that occurred more than 10 years before the date the lawsuit was filed.

(b-1) On request by the state, the state is entitled to be served with copies of all pleadings filed in the action and be provided at the state's expense with copies of all deposition transcripts. If the person bringing the action proceeds without the state's participation, the court, without limiting the status and right of that person, may permit the state to intervene at a later date on a showing of good cause.

Added by Acts 1997, 75th Leg., ch. 1153, Sec. 4.08, eff. Sept. 1, 1997.

Amended by:

Acts 2005, 79th Leg., Ch. 806 (S.B. 563), Sec. 12, eff. September 1, 2005.

Acts 2007, 80th Leg., R.S., Ch. 29 (S.B. 362), Sec. 3, eff. May 4, 2007.

Acts 2007, 80th Leg., R.S., Ch. 29 (S.B. 362), Sec. 4, eff. May 4, 2007.

Acts 2013, 83rd Leg., R.S., Ch. 572 (S.B. 746), Sec. 2, eff. September 1, 2013.

The 19 cases that cite Tex. Hum. Res. Code § 36.104 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENUnited States ex rel. Wood v. Allergan, Inc., 246 F. Supp. 3d 772 (S.D.N.Y. 2017).
cites § 36.104 2×cited by 33 cases
Where it cites § 36.104
“Compare Tex. Hum. Res. Code Ann. § 36.104 (2001), with Tex.”
The case’s holding
Anything of value in any form may constitute remuneration under the Anti-Kickback Statute for purposes of the False Claims Act.
Later courts cite it for
“expansively to include anything of value in any form whatsoever.” · 4 citing courts
2
GREENUS ex rel. Wall v. Vista Hospice Care, Inc., 778 F. Supp. 2d 709 (N.D. Tex. 2011).
cites § 36.104 3×subsections: (b)cited by 22 cases
Where it cites § 36.104
“104(b) (Vernon 1997) (amended 2007) (current version at Tex. Hum. Res.Code Ann. § 36.104 (Vernon 2009)).”
Later courts cite it for
“does not read that form as mandating an extension of fca liability to- every statement certifying compliance with any medicare statute or regulation relating to conditions of participation.” · 1 citing court
3
GREENUnited States ex rel. Foster v. Bristol-Myers Squibb Co., 587 F. Supp. 2d 805 (E.D. Tex. 2008).
cites § 36.104 2×subsections: (b)cited by 16 cases
Where it cites § 36.104
“See Tex. Hum. Res.Code § 36.104 (Vernon 1997).”
4
GREENUnited States v. Planned Parenthood Gulf Coast, Inc., 21 F. Supp. 3d 825 (S.D. Tex. 2014).
cites § 36.104 3×subsections: (b) 3×cited by 8 cases
Where it cites § 36.104
“Laws 4324 , 4346 (amended 2007) (current version at Tex. Hum. Res.Code Ann. § 36.104(b) (West Supp.”
5
GREENUnited States v. Catholic Health Initiatives, 312 F. Supp. 3d 584 (S.D. Tex. 2018).
cites § 36.104 1×cited by 10 cases
Where it cites § 36.104
“Tex. Hum. Res. Code § 36.104. The Court will accept the state's Statement.”
Later courts cite it for
“due to 1320a-7b(g), liability under the fca for aks violations does not require the defendants to have expressly certified their compliance with the aks.” · 1 citing court
6
GREENUnited States ex rel. Streck v. Allergan, Inc., 894 F. Supp. 2d 584 (E.D. Pa. 2012).
cites § 36.104 1×cited by 24 cases
Where it cites § 36.104
“See Tex. Hum. Res. Code Ann. § 36.104 (West Supp.”
7
GREENUnited States ex rel. Lisitza v. Johnson & Johnson, 765 F. Supp. 2d 112 (D. Mass. 2011).
cites § 36.104 1×cited by 17 cases
Where it cites § 36.104
“See Tex. Hum. Res. Code Ann. § 36.104 (b) (1997).”
Later courts cite it for
“the court agrees that, for purposes of prior disclosure, specifying a formulaic drug as part of a kickback scheme is synonymous with naming the company that produces it.” · 2 citing courts
8
NO FLAGIn re Novartis Pharm. Corp. v. the State of Texas, No. 15-25-00207-CV (Tex. App.—15th Dist. Nov. 14, 2025).
cites § 36.104 40×subsections: (b) 13× (a)(1) 5× (a)(2) 4×cited by 0 cases
Where it cites § 36.104
“V, § 21 498 Tex. Hum. Res. Code § 36.101 499 Tex. Hum.”
9
GREENUnited States v. Amgen, Inc., 336 F. Supp. 3d 119 (E.D.N.Y. 2018).
cites § 36.104 1×cited by 3 cases
Where it cites § 36.104
“Oncology or the dates on which said conduct occurred, the Court cannot determine whether, and to what extent, the pre-amendment version of Tex. Hum. Res. Code Ann. § 36.104 (b) is applicable to this cause of action.”
10
NO FLAGIn re Novartis Pharm. Corp. v. the State of Texas, No. 15-25-00207-CV (Tex. App.—15th Dist. Nov. 14, 2025).
cites § 36.104 23×subsections: (a) 3× (b) 3×cited by 0 cases
Where it cites § 36.104
“18 Tex. Hum. Res. Code Ann. § 36.102 (e)....”
11
NO FLAGIn re AstraZeneca Pharm. LP v. the State of Texas, No. 15-25-00088-CV (Tex. App.—15th Dist. Aug. 20, 2025).
cites § 36.104 4×cited by 0 cases
Summary
No passage or summary on file for this case yet.
12
NO FLAGIn re Dr. Robert Tafel, No. 24-1062 (Tex. June 19, 2026).
cites § 36.104 4×subsections: (b) 2×cited by 0 cases
Where it cites § 36.104
“Whether 1 See Tex. Hum. Res. Code §§ 36.104(b-1), .107, .”
13
NO FLAGDr. Robert Tafel v. D.S.L., No. 15-25-00083-CV (Tex. App.—15th Dist. June 26, 2025).
cites § 36.104 3×cited by 0 cases
Where it cites § 36.104
“Family Dentistry; Plaza De Oro Dental PA d/b/a Bear Creek Family Dentistry; Torre Vista Dental, PA d/b/a Bear Creek Family Dentistry; Town North Dental, PA d/b/a Bear Creek Family Dentistry; Bear Creek Family Dentistry PA d/b/a Bear Creek Family Dentistry; Mesquite Crossing…”
14
NO FLAGIn re Novartis Pharm. Corp. v. the State of Texas, No. 15-25-00207-CV (Tex. App.—15th Dist. Nov. 21, 2025).
cites § 36.104 3×subsections: (b) 3×cited by 0 cases
Summary
No passage or summary on file for this case yet.
15
GREENIn re Sanofi-Aventis U.S. LLC v. the State of Texas, 711 S.W.3d 732 (Tex. App.—15th Dist. 2025).
cites § 36.104 1×subsections: (b)cited by 0 cases
Where it cites § 36.104
“Tex. Hum. Res. Code § 36.104(b). Of course, those provisions apply only when the Attorney General opts not to assume “primary responsibility for prosecut- ing the action” from the outset.”
The case’s holding
A notice of supplemental authority attaching the State's merits brief in a qui tam suit is not a reasoned ruling; it notes the relator apparently recognized a deficiency of proof on venue.
16
NO FLAGIn re Novartis Pharm. Corp. v. the State of Texas, No. 15-25-00207-CV (Apr. 30, 2026).
cites § 36.104 2×cited by 0 cases
Where it cites § 36.104
“23 discretion to decide whether allowing a private party to proceed unilaterally to exercise uniquely public duties violates the Texas Constitution; that is ultimately for courts.105 When traditional civil claims are commandeered for use as “vehicles for commercial investment”…”
17
NO FLAGState of Texas v. Xerox Corp. Settlement Proceeds, No. 15-25-00034-CV (Tex. App.—15th Dist. July 10, 2025).
cites § 36.104 1×subsections: (a)cited by 0 cases
Summary
No passage or summary on file for this case yet.
18
NO FLAGState of Texas ex rel. Joshua LaFountain v. BLT Mgmt. Co., No. 15-25-00067-CV (Tex. App.—15th Dist. Sept. 19, 2025).
cites § 36.104 1×cited by 0 cases
Where it cites § 36.104
“51 Tex. Hum. Res. Code § 36.101(a)…………………………………………………3 Tex.”
19
NO FLAGDoe v. Univ. of Texas Health Sci. Ctr. at Houston, No. 4:21-cv-01574 (S.D. Tex. Aug. 27, 2025).
cites § 36.104 1×subsections: (b)cited by 0 casesunknown
Where it cites § 36.104
“Tex. Hum. Res. Code § 36.104(b). The court has not found, and the parties have not provided, any Texas state court cases interpreting this provision of the THFPA.”

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
200820172026

One bar per year. Tallest: 9 cases in 2025. 2026 is a partial year. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
Tex. App.8S.D. Tex.3D. Mass.1E.D.N.Y1S.D.N.Y.1E.D. Pa.1Tex.1txctapp151

The 8 courts with the most citing cases, of 10 courts in all.

By subsection
(a)2 cases
In re Novartis Pharm. Corp. v. the State of Texas, No. 15-25-00207-CV (Tex. App.—15th Dist. Nov. 14, 2025).“18 Tex. Hum. Res. Code Ann. § 36.102 (e)....”
State of Texas v. Xerox Corp. Settlement Proceeds, No. 15-25-00034-CV (Tex. App.—15th Dist. July 10, 2025).
(a)(1)1 case
In re Novartis Pharm. Corp. v. the State of Texas, No. 15-25-00207-CV (Tex. App.—15th Dist. Nov. 14, 2025).“V, § 21 498 Tex. Hum. Res. Code § 36.101 499 Tex. Hum.”
(a)(2)1 case
In re Novartis Pharm. Corp. v. the State of Texas, No. 15-25-00207-CV (Tex. App.—15th Dist. Nov. 14, 2025).
(b)9 cases
United States v. Planned Parenthood Gulf Coast, Inc., 21 F. Supp. 3d 825 (S.D. Tex. 2014).“Laws 4324 , 4346 (amended 2007) (current version at Tex. Hum. Res.Code Ann. § 36.104(b) (West Supp.”
US ex rel. Wall v. Vista Hospice Care, Inc., 778 F. Supp. 2d 709 (N.D. Tex. 2011).“104(b) (Vernon 1997) (amended 2007) (current version at Tex. Hum. Res.Code Ann. § 36.104 (Vernon 2009)).”
United States ex rel. Foster v. Bristol-Myers Squibb Co., 587 F. Supp. 2d 805 (E.D. Tex. 2008).“See Tex. Hum. Res.Code § 36.104 (Vernon 1997).”
In re Novartis Pharm. Corp. v. the State of Texas, No. 15-25-00207-CV (Tex. App.—15th Dist. Nov. 14, 2025).
In re Novartis Pharm. Corp. v. the State of Texas, No. 15-25-00207-CV (Tex. App.—15th Dist. Nov. 21, 2025).
Showing the top 5 of 9. More in the list view →
Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: laws through the 89th Legislature (2025). Syfert holds no earlier or later version of this section.

Texas Codes Home  |  Search Texas  |  Search cases for this section  |  syfert.com